Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.
about
Traditional Chinese medicine for modern treatment of Parkinson's disease.The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortexIs Ginkgo biloba and/or a Multivitamin-multimineral Supplement a Therapeutic Option for Parkinson's Disease? A Case ReportNeuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson's disease.Ginkgo biloba extract in an animal model of Parkinson's disease: a systematic review.Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic proteinEffect of formaldehyde on cell proliferation and death.Polyphenols Beyond Barriers: A Glimpse into the Brain.Protective effects of two constituents of Chinese herbs on spinal motor neurons from embryonic rats with hypoxia injury.Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia.Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple MechanismsBilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma.Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats.Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.
P2860
Q30572208-32CBD35B-3B73-4936-9C15-AA6A30A05CF0Q33685944-DFDE9BD0-B6B4-43F2-A122-DAD0B1F57661Q33924511-29A7DECA-AF63-468D-B2DD-7E8DAFD83D3DQ34733383-36471394-8DD7-4AEC-8D98-F9B59CD38BDAQ35079320-0C3DC191-7F2E-4FD8-B4E1-C41E2098AC1AQ36202870-1723D86A-BC12-4A81-8BE7-6708C47A11C1Q37808505-588FF136-512A-4708-A7CF-21C712D3EE92Q38991608-C0AECFC2-E6C5-46D6-90C7-9C34F731F246Q39420020-F593D769-0FCC-48B0-8C27-937FB7BA5D96Q41158844-90262F6D-DC5C-430F-BAE4-34B531ED248EQ41622472-601F375B-D53B-47E8-AF40-3EB15FA78FFAQ42172054-DAE3090E-1247-4D66-BCE3-B76E73CE89A2Q44772456-7E34ECD7-DD7B-489F-BC48-65091E052BF1Q46386528-B89E6FBD-D323-4B50-9896-5CCA29230C99Q46458937-FF45000C-F9FC-4C2F-9971-833579E55E31Q46496568-6F859213-B336-4C47-AEE7-954BEC93DCA5Q55384361-DEAE2756-CCC9-4B75-8275-CB5B066C220A
P2860
Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@en
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@nl
type
label
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@en
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@nl
prefLabel
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@en
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@nl
P1433
P1476
Involvement of monoamine oxida ...... minergic toxicity in C57 mice.
@en
P304
P356
10.1016/S0024-3205(99)00232-5
P407
P577
1999-01-01T00:00:00Z